Evidence map›Paper›PMID 28076756›Full record

ArticleStem cell reports2017

Dissociation of Survival, Proliferation, and State Control in Human Hematopoietic Stem Cells.

David J H F Knapp, Colin A Hammond, Paul H Miller, Gabrielle M Rabu, Philip A Beer, Marketa Ricicova, Véronique Lecault, Daniel Da Costa, Michael VanInsberghe, Alice M Cheung and 4 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Single-cell analysis identifies a CD33Nature cell biology · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

David J H F KnappTerry Fox Laboratory, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10(th) Avenue, Vancouver, BC V5Z 1L3, Canada.
Colin A HammondTerry Fox Laboratory, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10(th) Avenue, Vancouver, BC V5Z 1L3, Canada.
Paul H MillerTerry Fox Laboratory, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10(th) Avenue, Vancouver, BC V5Z 1L3, Canada.
Gabrielle M RabuTerry Fox Laboratory, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10(th) Avenue, Vancouver, BC V5Z 1L3, Canada.
Philip A BeerTerry Fox Laboratory, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10(th) Avenue, Vancouver, BC V5Z 1L3, Canada.
Marketa RicicovaAbCellera Biologics Inc, Vancouver, BC V6T 1Z4, Canada.
Véronique LecaultAbCellera Biologics Inc, Vancouver, BC V6T 1Z4, Canada; Centre for High-Throughput Biology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Daniel Da CostaAbCellera Biologics Inc, Vancouver, BC V6T 1Z4, Canada; Centre for High-Throughput Biology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Michael VanInsbergheCentre for High-Throughput Biology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Alice M CheungTerry Fox Laboratory, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10(th) Avenue, Vancouver, BC V5Z 1L3, Canada.
Davide PellacaniTerry Fox Laboratory, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10(th) Avenue, Vancouver, BC V5Z 1L3, Canada.
James PiretMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Carl HansenCentre for High-Throughput Biology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Connie J EavesTerry Fox Laboratory, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10(th) Avenue, Vancouver, BC V5Z 1L3, Canada. Electronic address: ceaves@bccrc.ca.
BC Cancer Agency · CAUniversity of British Columbia · CAAbCellera (Canada) · CACanada's Michael Smith Genome Sciences Centre · CA

Funding

CIHR
6 · The paper itself

Abstract

The role of growth factors (GFs) in controlling the biology of human hematopoietic stem cells (HSCs) remains limited by a lack of information concerning the individual and combined effects of GFs directly on the survival, Mitogenesis, and regenerative activity of highly purified human HSCs. We show that the initial input HSC activity of such a purified starting population of human cord blood cells can be fully maintained over a 21-day period in serum-free medium containing five GFs alone. HSC survival was partially supported by any one of these GFs, but none were essential, and different combinations of GFs variably stimulated HSC proliferation. However, serial transplantability was not detectably compromised by many conditions that reduced human HSC proliferation and/or survival. These results demonstrate the dissociated control of these three human HSC bio-responses, and set the stage for future improvements in strategies to modify and expand human HSCs ex vivo.

Indexed as

Cell DifferentiationCell ProliferationCell SurvivalAnimalsBiomarkersCells, CulturedHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHumansIntegrin alpha6Intercellular Signaling Peptides and ProteinsIn Vitro TechniquesMicePhenotypeBiomarkersIntegrin alpha6Intercellular Signaling Peptides and Proteinsapoptosiscell deathgrowth factorhematopoietic stem cellHSChumanmicrofluidicsmitogenesisproliferationself-renewalsurvivaltransplantationxenotransplantation

Identifiers

PMID28076756
PMCPMC5233451
OpenAlexW2571355254

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.